In the Pharmaceutical industry, technology transfer has become a prominent trend. This is the process by which a developer of technology makes the technology and skills available to another commercial partner.

In the Pharmaceutical industry, technology transfer has become a prominent trend. This is the process by which a developer of technology makes the technology and skills available to another commercial partner. The main objective of technology transfer is to form alliances with partners that can progress the development of the technology and take it to the market. The discovery of a pharmaceutical product may only have the capability to take the product through various stages. To take the product through its clinical and regulatory phases, it may be imperative to adopt technology transfer services. The final stage involves presenting the product to the market. The parties involved in technology transfer services must be willing to work together, step by step for a successful outcome.

In the pharmaceutical industry, technology transfer is considered as a collaborative approach to improve global health. Low and middle income countries benefit a lot from technology transfer services. Through technology transfer, developing countries are able to access knowledge, experience and equipment related to advanced and innovative industrial products and processes.

There is no better method to bridge the Research and Development (R&D) and access gap in developing countries than through technology transfer. Some of the factors that may reinforce technology transfer services include political stability and good economic governance, availability of skilled workers, strong intellectual property rights as well as effective enforcement and quality relationship between the parties involved in technology transfer. The parties involved must be able to work together for long periods of time. Teamwork is a key ingredient for effective technology transfer services while disunity is a key impediment to success.

Apparently, technology transfer is more than simply handing over technology. The transfer of R&D pharmaceuticals occurs through many channels. There are various elements of technology transfer package and they include transfer of physical objects. Physical objects such as equipment for use in research laboratories and manufacturing equipment can be handed over to the recipient by the company offering technology transfer services.

The technology transfer services also feature skills and human aspects of technology management and learning. For instance, a training course for researchers may be organized where the personnel are equipped with vast technical know how and skills regarding pharmaceuticals. This is one of the most effective methods of tech transfer; the recipients are able to master the various pharmaceutical processes and procedures.

In addition, technology transfer involves handing over of techniques, organizational and procedural knowledge needed to operate a given technology relating to pharmaceutical products. The main goal for tech transfer in pharma is to promote health and social development through spreading of scientific knowledge.

Since the process of developing drugs and pharmaceuticals is not only time consuming but also complex, many companies turn to technology transfer services. Surveys indicate that well organized and planned technology transfer procedures can be used as tools for gaining a competitive edge by many companies. A clear and a straight forward communication channel must be maintained between the various parties involved in the technology transfer process. Chances of success can be highly dwindled where the participating parties fail to work together. After all, how can knowledge and skills be passed down from the CMO to the recipients without a proper communication channel?

Resources:
Ian Moore is the author of this article on Technology transfer.
Find more information on Technology transfer services here

Author: Ian Moore.

This author has published 1 articles so far. More info about the author is coming soon.